These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26904535)

  • 1. The Influence of Neurocognitive Impairment on HIV Risk Behaviors and Intervention Outcomes among High-Risk Substance Users: A Systematic Review.
    Shrestha R; Copenhaver M
    Front Public Health; 2016; 4():16. PubMed ID: 26904535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive impairment and HIV risk factors: a reciprocal relationship.
    Anand P; Springer SA; Copenhaver MM; Altice FL
    AIDS Behav; 2010 Dec; 14(6):1213-26. PubMed ID: 20232242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment.
    Huedo-Medina TB; Shrestha R; Copenhaver M
    AIDS Behav; 2016 Aug; 20(8):1646-57. PubMed ID: 27052845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS.
    Ezeabogu I; Copenhaver MM; Potrepka J
    AIDS Care; 2012; 24(3):386-93. PubMed ID: 22250847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment.
    Shrestha R; Karki P; Huedo-Medina TB; Copenhaver M
    J Assoc Nurses AIDS Care; 2017; 28(1):85-94. PubMed ID: 27769735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self-Report Neurocognitive Symptoms by High-Risk Drug Users: A Mediation Analysis.
    Shrestha R; Karki P; Huedo-Medina TB; Copenhaver M
    J Assoc Nurses AIDS Care; 2017; 28(4):612-621. PubMed ID: 28478870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-Related Differences in Self-Reported Neurocognitive Impairment among High-Risk Cocaine Users in Methadone Maintenance Treatment Program.
    Shrestha R; Huedo-Medina TB; Copenhaver MM
    Subst Abuse; 2015; 9():17-24. PubMed ID: 25861219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.
    Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH
    Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV prevention intervention for substance users: a review of the literature.
    Elkbuli A; Polcz V; Dowd B; McKenney M; Prado G
    Subst Abuse Treat Prev Policy; 2019 Jan; 14(1):1. PubMed ID: 30606266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment.
    Copenhaver M; Avants SK; Warburton LA; Margolin A
    J Psychoactive Drugs; 2003; 35(2):209-18. PubMed ID: 12924743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An experiential program to reduce AIDS risk among female sex partners of injection-drug users.
    Rhodes F; Wolitski RJ; Thornton-Johnson S
    Health Soc Work; 1992 Nov; 17(4):261-72. PubMed ID: 1478552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research.
    Shrestha R; Altice F; Karki P; Copenhaver M
    Front Immunol; 2017; 8():561. PubMed ID: 28553295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cognitive-behavioral intervention to reduce HIV risk behaviors in crack and injection drug users.
    Hershberger SL; Wood MM; Fisher DG
    AIDS Behav; 2003 Sep; 7(3):229-43. PubMed ID: 14586186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project.
    Parsons JT; Rosof E; Punzalan JC; Di Maria L
    AIDS Patient Care STDS; 2005 Jan; 19(1):31-9. PubMed ID: 15665633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An explanatory factor analysis of a brief self-report scale to detect neurocognitive impairment among HIV-positive men who have sex with men and transgender women in Peru.
    Weikum D; Shrestha R; Ferro EG; Vagenas P; Copenhaver M; Spudich S; Alpert MD; Cabello R; Lama JR; Sanchez J; Altice FL
    AIDS Care; 2017 Oct; 29(10):1297-1301. PubMed ID: 28449599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation and National Dissemination of a Brief, Evidence-Based, HIV Prevention Intervention for High-Risk Men Who Have Sex with Men.
    Herbst JH; Raiford JL; Carry MG; Wilkes AL; Ellington RD; Whittier DK
    MMWR Suppl; 2016 Feb; 65(1):42-50. PubMed ID: 26916033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the Acceptability of mHealth Technology in HIV Prevention Among High-Risk Drug Users in Treatment.
    Shrestha R; Huedo-Medina TB; Altice FL; Krishnan A; Copenhaver M
    AIDS Behav; 2017 Nov; 21(11):3100-3110. PubMed ID: 28025735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance abuse in early adolescents and HIV preventive behaviors: findings from a school-based cross-sectional survey for the period from 2009 to 2013, Bangkok Thailand.
    Thepthien B; Altaf L; Chuchareon P; Srivanichakron S
    AIDS Care; 2016 Oct; 28(10):1327-31. PubMed ID: 27120264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.